Thomas Rano, Ph.D.
About Thomas Rano, Ph.D.
Thomas Rano, Ph.D., is a Clinical Scientist Team Lead in Cardiovascular at Bristol Myers Squibb with extensive experience in clinical research and medical affairs across multiple pharmaceutical companies.
Current Role and Responsibilities
Thomas Rano, Ph.D., currently serves as Clinical Scientist Team Lead in Cardiovascular at Bristol Myers Squibb. In this role, he leads cardiovascular clinical trials, contributing scientific insight and expertise in clinical trial design, protocol writing, pharmacodynamics, and pharmacokinetics to support ongoing clinical trials. He coordinates with project team members including Clinical Operations, Data Management, Statistics, Drug Safety, Regulatory, and Project Management to ensure the scientific integrity of clinical trials.
Previous Roles at Bristol Myers Squibb
Prior to his current role, Thomas Rano served as Director of Global Medical Affairs, Neurology at Bristol Myers Squibb from 2019 to 2021. During this time, he led the Ozanimod Multiple Sclerosis phase 3b and 4 clinical studies, demonstrating his expertise in neurology and clinical research.
Experience at Celgene
Thomas Rano's tenure at Celgene spanned from 2013 to 2019, where he first worked as a Clinical Research Scientist in Warren, NJ, and later as a Senior Clinical Research Scientist in Summit, NJ. Notably, he led the Ozanimod Ulcerative Colitis and Crohn's disease studies, contributing significantly to these clinical programs.
Early Career and Roles at Johnson & Johnson and Other Companies
Thomas Rano has an extensive background in clinical science, having worked as a Clinical Scientist at Johnson & Johnson from 2011 to 2013 in Raritan, NJ, and as Principal Scientist at Janssen Pharmaceutical from 2002 to 2011 in both Raritan, NJ, and Spring House, PA. He also held positions at 3-Dimensional Pharmaceuticals and Merck Research Laboratories, showcasing his long-standing involvement and expertise in the field.
Educational Background
Thomas Rano holds a Ph.D. in Organic Chemistry from the University of Pennsylvania. He also earned a Bachelor of Arts (BA) in Chemistry from Rutgers University. His academic background has laid a strong foundation for his extensive career in clinical research and scientific contributions.
Leadership in Clinical Trials
Thomas Rano has led numerous clinical trials throughout his career, including the Mavacampten clinical trials in his current role. His leadership extends to multiple clinical programs such as those for Ozanimod in treating Multiple Sclerosis, Ulcerative Colitis, and Crohn's disease, demonstrating his breadth of expertise in both cardiovascular and neurology domains.